Monday, May 10, 2021

Nuclear research and consultancy firm acquired by French company

French firm Egis has acquired a majority shareholding in Galson Sciences Ltd, an international consulting and research firm based in Oakham and specialising in radioactive waste management and disposal.

With a long-standing involvement in nuclear power-related activities, the acquisition is an “important step for Egis in fulfilling its ambition to broaden its skill base, missions and geographical footprint in a sector that is key for the transition to a low-carbon economy.”

The acquisition aligns with Egis’ strategic plan ‘Impact the Future’, and enables the Group
to extend its role as an architect engineer, becoming active throughout the entire nuclear lifecycle.

Galson Sciences helps clients take decisions – by performing technical studies and strategic
evaluations, and by obtaining approvals for selected management options. The company
undertakes multidisciplinary studies covering all aspects of the radioactive waste lifecycle, including inventory analysis, waste treatment, conditioning, and packaging, interim storage, transport and disposal.

The company has particular expertise in preparing disposal safety cases for all kinds of radioactive waste, environmental safety cases for decommissioning, research on pre-disposal management options for problematic radioactive wastes, criticality safety assessment and lifecycle cost assessment.

Galson Sciences is a key partner to the Nuclear Decommissioning Authority (NDA) and its subsidiaries RWM, Magnox, DSRL, Sellafield Ltd and LLWR Ltd.

François Martin, director of Nuclear business activity at Egis, said: “We at Egis are delighted to welcome Galson Sciences, whose internationally acknowledged expertise in radioactive waste management should generate some excellent synergies with our current nuclear sector activities and offer diversification into the back-end nuclear cycle.

“Galson Sciences’ business is perfectly consistent with our position in this industry and with our corporate social responsibility, which is to supply our clients with safe infrastructure solutions for nuclear power.”

Daniel Galson, Managing Director and founder of Galson Sciences, said: “We are excited to be joining the Egis group.

“Egis will bring additional capability to our clients in the UK and internationally by expanding the range and depth of experience that we are able to offer in support of radioactive waste management solutions, and will help us grow the business by providing our highly skilled staff with additional opportunities.

“Egis’ core values of innovation in service delivery, sustainability and ethical behaviour, and concern for staff development and wellbeing match our own, and I am convinced that Egis is an excellent new home for the company.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.

Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.